SESSION I - Immunotherapy and targeted therapy in lymphoid malignancies I

News and views in aggressive lymphomas
C. Carlo-Stella
News and views in Hodgkin lymphoma
C. Rusconi
News and views in acute lymphoblastic leukemia
A. Rambaldi
SESSION II - Immunotherapy and targeted therapy in lymphoid malignancies II

Tumor-host interactions as determinants of immunotherapy responses in CLL
M. Seiffert
SESSION III - Immunotherapy and targeted therapy in myeloid malignancies

CAR-T in AML: ready for prime time?
S. Tettamanti
Immune dysregulation and driver mutations in myeloid malignancies
A. Curti
SESSION IV - Expanding CAR-T cell applications and efficafy

CAR-T cell therapy in autoimmune diseases
M. Hagen
SESSION VI - Exploring innovative cell-therapy approaches II

Personalized oncolytic virotherapy
V. Cerullo
An immune portfolio for ALK tumors: from vaccine to cellular immunotherapies
R. Chiarle
SESSION VII - Immunological hints from solid tumors

Neoantigens based vaccines in cancer preventio
E. Scarselli
Privacy Policy | Cookie Policy